Calithera Biosciences, Inc.
CALA
$0.0001
$0.000.00%
OTC PK
| 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Revenue | -- | 0.00 | 6.75M | 9.75M | 9.75M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 0.00 | 6.75M | 9.75M | 9.75M |
| Cost of Revenue | 28.53M | 37.51M | 42.62M | 47.68M | 53.46M |
| Gross Profit | -28.53M | -37.51M | -35.87M | -37.93M | -43.71M |
| SG&A Expenses | 13.54M | 15.55M | 18.82M | 19.69M | 20.85M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 42.07M | 103.94M | 112.31M | 118.24M | 125.18M |
| Operating Income | -42.07M | -103.94M | -105.56M | -108.49M | -115.43M |
| Income Before Tax | -39.65M | -101.92M | -103.29M | -108.53M | -115.09M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -39.65 | -101.92 | -103.29 | -108.53 | -115.09 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -39.65M | -101.92M | -103.29M | -108.53M | -115.09M |
| EBIT | -42.07M | -103.94M | -105.56M | -108.49M | -115.43M |
| EBITDA | -41.82M | -103.68M | -105.30M | -108.22M | -115.15M |
| EPS Basic | -4.98 | -22.01 | -23.01 | -28.50 | -30.98 |
| Normalized Basic EPS | -5.52 | -16.16 | -16.78 | -18.03 | -19.42 |
| EPS Diluted | -8.21 | -25.23 | -26.23 | -28.50 | -30.98 |
| Normalized Diluted EPS | -5.35 | -15.99 | -16.61 | -18.03 | -19.42 |
| Average Basic Shares Outstanding | 18.53M | 17.41M | 16.25M | 15.09M | 14.77M |
| Average Diluted Shares Outstanding | 19.36M | 18.24M | 17.09M | 15.09M | 14.77M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |